.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Covington
Boehringer Ingelheim
McKinsey
Novartis
Julphar
Healthtrust
Queensland Health
Merck
Express Scripts

Generated: June 22, 2017

DrugPatentWatch Database Preview

PROTONIX Drug Profile

« Back to Dashboard

Which patents cover Protonix, and what generic Protonix alternatives are available?

Protonix is a drug marketed by Wyeth Pharms Inc and is included in three NDAs. There are eight patents protecting this drug and one Paragraph IV challenge.

This drug has forty-six patent family members in thirty-three countries.

The generic ingredient in PROTONIX is pantoprazole sodium. There are forty-six drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.

Summary for Tradename: PROTONIX

Patents:5
Applicants:1
NDAs:3
Suppliers / Packagers: see list13
Bulk Api Vendors: see list43
Clinical Trials: see list26
Patent Applications: see list3,710
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROTONIX at DailyMed

Pharmacology for Tradename: PROTONIX

Drug ClassProton Pump Inhibitor
Mechanism of ActionProton Pump Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
FOR SUSPENSION, DELAYED RELEASE;ORAL022020-001Nov 14, 2007RXYesYes7,544,370*PED► SubscribeY► Subscribe
Wyeth Pharms Inc
PROTONIX IV
pantoprazole sodium
INJECTABLE;IV (INFUSION)020988-001Mar 22, 2001APRXYesYes6,780,881*PED► SubscribeY► Subscribe
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
FOR SUSPENSION, DELAYED RELEASE;ORAL022020-001Nov 14, 2007RXYesYes7,838,027*PED► SubscribeY► Subscribe
Wyeth Pharms Inc
PROTONIX IV
pantoprazole sodium
INJECTABLE;IV (INFUSION)020988-001Mar 22, 2001APRXYesYes7,351,723*PED► SubscribeY► Subscribe
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
FOR SUSPENSION, DELAYED RELEASE;ORAL022020-001Nov 14, 2007RXYesYes7,550,153*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROTONIX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL020987-002Jun 12, 20015,997,903*PED► Subscribe
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL020987-001Feb 2, 20004,758,579*PED► Subscribe
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
FOR SUSPENSION, DELAYED RELEASE;ORAL022020-001Nov 14, 20074,758,579*PED► Subscribe
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL020987-002Jun 12, 20014,758,579*PED► Subscribe
Wyeth Pharms Inc
PROTONIX
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL020987-001Feb 2, 20005,997,903*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: PROTONIX

Drugname Dosage Strength RLD Submissiondate
pantoprazole sodiumDelayed-release Tablets20 mg and 40 mgProtonix2/2/2004

International Patent Family for Tradename: PROTONIX

Country Document Number Estimated Expiration
HungaryT68978► Subscribe
Norway303714► Subscribe
Hong Kong1005851► Subscribe
European Patent Office0519365► Subscribe
Czech Republic9302764► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PROTONIX

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB96/056United Kingdom► SubscribePRODUCT NAME: PANTOPRAZOLE AND ITS SALTS, HYDRATES AND HYDRATES OF ITS SALTS; REGISTERED: SE SE12131 19940506; UK 04889/0010 19960604
C0032Belgium► SubscribePRODUCT NAME: PANTOPRAZOL. NATR. SESQUIHYDRAS PANTOPRAZOLE; NAT. REGISTRATION NO/DATE: 127 IS 98 F 3 19960222; FIRST REGISTRATION: SE 12131 19940506
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
US Army
Harvard Business School
Cipla
McKinsey
UBS
Fish and Richardson
Medtronic
US Department of Justice
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot